Quotient Sciences, a global drug development, research and manufacturing accelerator, and Biorasi, a global clinical research organization (CRO), have partnered to deliver fully integrated early phase clinical trial solutions. The partnership will combine Quotient Sciences’ expertise in early clinical development with Biorasi’s global patient recruitment capabilities to provide biotech and pharma Sponsors with a simplified, efficient pathway from Investigational New Drug (IND) to proof-of-con...